ORIGINAL RESEARCH article
Front. Immunol.
Sec. T Cell Biology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1667851
Essential roles of CTCF binding sites at TAD boundaries in modulating chromatin interactions and transcriptional regulation at the Ifng locus
Provisionally accepted- 1Fukushima Medical University, Fukushima, Japan
- 2Sendai City Public Health Center, Sendai, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Interferon-g (IFN-g) is a key cytokine essential for host defense and tumor surveillance, and its expression in T cells is tightly regulated by long-range enhancer–promoter interactions within the Ifng locus. These interactions are organized within topologically associating domains (TADs) and subdomains (intra-TADs), whose boundaries are defined by the architectural protein CTCF. However, the specific contribution of these boundaries to Ifng regulation and chromatin architecture remains incompletely understood. Here, we investigated how chromatin looping within the TAD affects Ifng expression by using chromosome conformation capture (3C) and RNA sequencing in CRISPR-Cas9 genome editing in mice. Deletion of a single CTCF binding site (CBS) at the TAD boundary markedly impaired Th1-mediated immune responses against Cryptococcus neoformans infection and B16 melanoma. This deletion disrupted enhancer– promoter contacts and diminished enhancer-driven activation of Ifng. In contrast, deletion of a CBS within an intra-TAD boundary had no detectable impact on Ifng transcription. Collectively, these findings highlight the essential role of boundary-associated CBS elements in shaping chromatin architecture that enables enhancer–promoter communication and proper transcriptional regulation of the Ifng locus.
Keywords: IFN-g, CTCF, TAD, intra-TAD, Enhancer, transcription, Chromatin architecture
Received: 17 Jul 2025; Accepted: 12 Sep 2025.
Copyright: © 2025 Muto, Yoshida, Suzuki, Yamamoto, Inoue, Murakami-Sekimata, Iseki and Sekimata. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Masayuki Sekimata, Fukushima Medical University, Fukushima, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.